close
MENU
Hot Topic Hawke’s Bay
Hot Topic Hawke’s Bay
3 mins to read

Former F&P Healthcare boss wins Beacon leadership award

Mike Daniell's long career with the company is a "remarkable story of dedication, drive, and determination".

Fiona Rotherham
Thu, 01 Dec 2016

Michael Daniell, the former boss and current director of Fisher & Paykel Healthcare, has won the New Zealand Shareholders Association's 2016 Beacon Award for guiding the company from a tiny startup with a handful of staff to a recognised world leader in the production of respiratory care and sleep apnea devices.

The annual award is given to someone who demonstrates outstanding performance, including leadership, corporate governance, and respecting the rights of all shareholders.

NZSA chairman John Hawkins says Mr Daniell's long career with the company is a "remarkable story of dedication, drive, and determination which has taken F&P Healthcare to the very pinnacle, including being named Exporter of the Year in 2015."

It's hard getting a man as modest as Mr Daniell to say much about himself, he prefers talking about the people at F&P Healthcare where the culture of treating others fairly and an export vision was inculcated by the founders Maurice Paykel and Woolf Fisher and drummed into him by his mentor, Dave O'Hare, the company's former medical division head.

He says the award recognises that F&P Healthcare's people, "including myself as a small part of that, will do the right thing, the right thing for the business and for all the other people including shareholders."

The right thing, he says, is acting with integrity and honesty.

Mr Daniell spent 37 years with the company, retiring as chief executive and managing director in March this year though he has remained on the board as an independent director.

He says he had no problem separating the role of management from that of corporate governance, given he already had experience as a director of Tait and as chairman of the governance board at the University of Auckland's Medical Technology Centre of Research Excellence.

He wouldn't mind picking up one more directorship but wants to avoid getting too busy so he can finally do the things the chief executive of a fast-growing global company never finds time for – things like taking photos and building computers in his garage as retired electrical engineers do.

F&P Healthcare was global from day one. Mr Daniell recalls the majority of the $250,000 annual revenue when he joined in 1979 came from outside New Zealand.

Today the medical device maker is forecasting a record annual result for the 2017 financial year of $880 million revenue and profit in a range of $165 million to $170 million. The target is to grow to a $1 billion revenue company but Mr Daniell says once that first target is hit, it should immediately aim for $2 billion given its low penetration in a huge potential market.

It has expanded the range of medical conditions its devices cover from respiratory to surgery and Mr Daniell says it has so far only a 10% penetration rate into the number of patients that could be treated by its products each year. With an ageing population and financially-strapped healthcare organisations looking for cost efficiencies, F&P Healthcare is well-placed to meet that growing demand, he says.

Achieving big ambitions is doable from New Zealand, which he says is not as geographically distant as people think given the working day overlaps with Asia and North America which are just one flight away.

He points to a number of high-tech companies on the annual TIN100 list that are poised for big global growth in the next few years and have the key factors to do so: the drive, good technology that meets a consumer need, and the right people. Beyond people, one of the keys to F&P Healthcare's success has been the 9% of revenue spent annually on research and development to stay at the forefront of its industry.

As to the rise of shareholder activism in New Zealand, Mr Daniell says it is good to have an organisation such as the NZ Shareholders' Association representing retail shareholders who often don't have a particularly strong voice. When he was running the medical device maker it had hundreds of meetings with institutional and other shareholders and had a good understanding of their view.

"It doesn't mean you do everything they want you to do. We have to think about the long term," he says.

Inaugural business journalism award winner

NBR reporter Tim Hunter also received an award from the NZ Shareholders' Association. Mr Hunter won the inaugural NZSA Business Story of the Year Award, for a series of three articles on Intueri. The judges praised the articles as intensely researched, tackling complex issues and demonstrating best journalistic practice.

"I am delighted and honoured to receive this inaugural award," Mr Hunter says.

"The NZSA a vital voice for investors in this country’s commercial life and business journalism benefits greatly from its support. The dinners are great too."

(BusinessDesk)

Fiona Rotherham
Thu, 01 Dec 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Former F&P Healthcare boss wins Beacon leadership award
63536
false